MBOT stock: buy or sell?
January 24th, 2020
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space.
Should I buy MBOT stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Microbot Medical stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Microbot Medical stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we collected 3 ratings published for MBOT stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
MBOT stock analysis
Shares of Microbot Medical plummed a bloodcurdling -7.93% and closed at $10.33.
Microbot Medical shares plummed -7.93% to $10.33 on Jan/24. Since SMA100d and SMA200d crossed up on January 13th, MBOT price slid a -21.56%. Since price and SMA200d lines crossed up on Dec/23, MBOT climbed $4.63 (81.23%).
Microbot Medical shares plummed -17.16% this week, ending at $10.33. Early January MBOT climbed an astounding 12.00% in just one week.
Having descending tops is not good news for investors in MBOT. Although it's only a warning signal, eyes should be on alert during next weeks to identify possible new risks. Sliding under its previous bottom at would confirm the downtrend path. Since SMA20w and SMA40w crossed up early January, MBOT price slid a -10.87%. Since price and SMA40w lines crossed up late December 2019, MBOT climbed $4.63 (81.23%).
MBOT stock price history
MBOT stock went public on May 2nd, 2003 with a price of $33,210.001. Since then, MBOT stock sliced a -100.00%, with a yearly average of -6.30%.
1: Adjusted price after possible price splits or reverse-splits.
MBOT stock historical price chart
MBOT stock reached 52-week highs on December/24 at $20.15, and all-time highs 2005-01-19 with a price of 109674.
MBOT stock price target is $10.00Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' MBOT stock price predictions in the hope that they will be met as they may be wrong and not met. We found 2 price predictions for MBOT stock published in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince last March, when Microbot Medical presented its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2015, Microbot Medical annual sales collapsed a hair-raising -88.45% to $0.12 M USD from $1.01 marked in 2014. When comparing 2015 vs 2014, in the same way, profit margin (that is, the net income divided by revenues) plunged a -27,919.96% to -31,154.02%.
|2012||$1.37 M||-||$-28.49 M-2079.6%||-|
|2013||$1.20 M||-12.41%||$-26.44 M-2203.3%||-7.20%|
|2014||$1.01 M||-15.63%||$-32.74 M-3234.1%||23.83%|
|2015||$0.12 M||-88.45%||$-36.42 M-31154.0%||11.22%|
Quarterly financial resultsReported quarter income marked $-2.13 million with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Microbot Medical sales marked a neutral move and stayed constant a nan%. Looking back to recent quarterly results, Microbot Medical posted 7 positive quarters in a row.
Microbot Medical ownershipWhen you are planning to buy shares of a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Microbot Medical, 10.42% of all outstanding shares are owned by its staff.
In case of Microbot Medical stock, 14.39% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MBOT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$74.3 M|
|Total shares||7.2 M|
|Float shares||4.0 M|
|- Institutional holdings (%)||14.4%|
|- Insider holdings (%)||10.4%|
|Shares in short selling||0.0%|
|Friday, January 24th, 2020|
|Day range||$10.11 - $11.22|
|Average true range||$1.19|
|50d mov avg||$8.15|
|100d mov avg||$6.86|
|200d mov avg||$6.49|
Microbot Medical performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We compared Microbot Medical against in the following table: